Table 1 Patient characteristics at baseline
n | % | ||
|---|---|---|---|
Age (years) | |||
Mean (SD) | 58 (11) | ||
Gender | |||
Male | 9 | 90 | |
Female | 1 | 10 | |
KPS (median, range) | 55 (50–70) | ||
Histology | Adenocarcinoma | 9 | 90 |
Squamous cell carcinoma | 1 | 10 | |
Localization metastases | |||
Thoracic | 7 | 70 | |
Lumbar | 3 | 30 | |
Number metastases | |||
Mean (range) | 2 (1–5) | ||
Solitary | 3 | 30 | |
Multiple | 7 | 70 | |
Type of metastases | |||
Mixed | 1 | 10 | |
Osteolytic | 9 | 90 | |
Distant metastases at baseline | |||
Visceral | 5 | 50 | |
Brain | 3 | 30 | |
Lung | 4 | 40 | |
Ambulatory status prior to RT | |||
Not ambulatory | 9 | 90 | |
Ambulatory before RT | 1 | 10 | |
Immunotherapy | 2 | 20 | |
Chemotherapy | 7 | 70 | |
Pathological fracture at baseline | 0 | 0 | |
Radiotherapy schedule (Gy) | |||
Single dose (median, range) | 3 (2.5-3) | ||
Cumulative dose (median, range) | 30 (30–35) | ||